Hosted on MSN47m
FDA grants ODD to NMD Pharma’s Charcot-Marie-Tooth disease therapy
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to NMD Pharma’s oral lead development programme, NMD670, designed to treat Charcot-Marie-Tooth disease (CMT). A ...
In the Presidents’ Club, Carter Was the Odd Man Out
Jimmy Carter’s relationship with his successors in the Oval Office, both Republicans and fellow Democrats, was generally ...